Mercer Capital Advisers, Inc. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Mercer Capital Advisers, Inc. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2020$17,000
+6.2%
2000.0%0.01%
-8.3%
Q1 2020$16,000
-5.9%
2000.0%0.01%
+20.0%
Q4 2019$17,0000.0%2000.0%0.01%
-9.1%
Q3 2019$17,000
+6.2%
2000.0%0.01%
+10.0%
Q2 2019$16,0000.0%2000.0%0.01%
-9.1%
Q1 2019$16,000
+23.1%
2000.0%0.01%
+10.0%
Q4 2018$13,000
-13.3%
2000.0%0.01%0.0%
Q3 2018$15,0000.0%2000.0%0.01%
-9.1%
Q2 2018$15,000
+15.4%
2000.0%0.01%
+10.0%
Q1 2018$13,0000.0%2000.0%0.01%
+11.1%
Q4 2017$13,0000.0%2000.0%0.01%
-10.0%
Q3 2017$13,000
+8.3%
2000.0%0.01%
+11.1%
Q2 2017$12,000
+20.0%
2000.0%0.01%
+12.5%
Q1 2017$10,000
+11.1%
2000.0%0.01%
+14.3%
Q4 2016$9,000
-10.0%
2000.0%0.01%
-12.5%
Q3 2016$10,000
+11.1%
2000.0%0.01%
+14.3%
Q2 2016$9,000
+12.5%
2000.0%0.01%0.0%
Q1 2016$8,0000.0%2000.0%0.01%0.0%
Q4 2015$8,000
+14.3%
2000.0%0.01%
+16.7%
Q3 2015$7,000
-50.0%
2000.0%0.01%
-53.8%
Q2 2015$14,0000.0%2000.0%0.01%0.0%
Q1 2015$14,000
-6.7%
2000.0%0.01%0.0%
Q4 2014$15,0002000.01%
Other shareholders
BAXTER INTL INC shareholders Q3 2023
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders